Ncs Testing Technology Co Ltd (300797) — Capital Reinvestment Ratio

Latest as of September 2025: 1.04x

Ncs Testing Technology Co Ltd (300797) has a Capital Reinvestment Ratio of 1.04x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥15.96 Million) in capital expenditures (CN¥16.54 Million). See Ncs Testing Technology Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.04x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥15.96 Million
CNY

Capital Expenditures

CN¥16.54 Million
CNY

Data as of

Sep 2025
Most recent filing

Ncs Testing Technology Co Ltd Capital Reinvestment Ratio (2015–2025)

This chart tracks Ncs Testing Technology Co Ltd's Capital Reinvestment Ratio across 11 annual periods.

Annual Capital Reinvestment Ratio for Ncs Testing Technology Co Ltd (2015–2025)

Year-by-year Capital Reinvestment Ratio for Ncs Testing Technology Co Ltd from 2015 to 2025. For live market cap and broader valuation context, see 300797 company net worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.50x CN¥210.53 Million CN¥104.61 Million ▼ -54.9%
2024 1.10x CN¥141.62 Million CN¥155.97 Million ▼ -36.1%
2023 1.72x CN¥95.78 Million CN¥165.04 Million ▲ +12.9%
2022 1.53x CN¥120.85 Million CN¥184.41 Million ▲ +24.5%
2021 1.23x CN¥100.67 Million CN¥123.41 Million ▲ +68.9%
2020 0.73x CN¥111.69 Million CN¥81.05 Million ▲ +3.8%
2019 0.70x CN¥68.22 Million CN¥47.70 Million ▼ -17.0%
2018 0.84x CN¥65.73 Million CN¥55.39 Million ▲ +22.5%
2017 0.69x CN¥19.88 Million CN¥13.67 Million ▼ -3.8%
2016 0.72x CN¥35.42 Million CN¥25.34 Million ▲ +224.3%
2015 0.22x CN¥65.26 Million CN¥14.40 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow